Results 21 to 30 of about 222,490 (305)
Pharmaceuticals, 2021 Background: Glioblastoma represents the most common primary brain tumor in adults. Despite technological advances, patients with this disease typically die within 1–2 years after diagnosis.
Marc-Eric Halatsch +8 more
doaj +1 more source
Compassion in emergency departments. Part 1: nursing students’ perspectives [PDF]
, 2018 Compassion is a topical issue in clinical nursing practice, nurse education and policy, but a review of the literature reveals that nursing students’ experiences of compassionate care receives little attention.
Howes, Dora +2 more
core +3 more sources
Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
Pharmaceuticals, 2021 Many bacteriophages are obligate killers of bacteria. That this property could be medically useful was first recognized over one hundred years ago, with 2021 being the 100-year anniversary of the first clinical phage therapy publication. Here we consider
Stephen T. Abedon +2 more
doaj +1 more source
Compassionate Treatment of Brainstem Tumors with Boron Neutron Capture Therapy: A Case Series
Life, 2022 Brainstem tumors are heterogenous and cancerous glioma tumors arising from the midbrain, pons, and the medulla that are relatively common in children, accounting for 10% to 20% of all pediatric brain tumors. However, the prognosis of aggressive brainstem
Yi-Wei Chen +31 more
doaj +1 more source
A qualitative exploration of responses to self-compassion in a non-clinical sample [PDF]
, 2016 Research suggests that being self-compassionate can have myriad benefits, including life satisfaction, health-promoting behaviours and improved mental health.
Campion, Maxine, Glover, Lesley
core +1 more source
Cancer Medicine, 2023 Purpose Medicines in special situations (MSS) refer to off‐label or to unlicensed drugs under investigation (compassionate use). Our objectives were to evaluate characteristics and to estimate overall survival (OS), event‐free survival (EFS), and the ...
Sandra Fontanals +6 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundRipretinib was recently approved for the fourth-line targeted therapy for advanced gastrointestinal stromal tumor (GIST) refractory to imatinib, sunitinib, and regorafenib based on the pivotal INVICTUS phase III study.
Li-Ching Lin +10 more
doaj +1 more source
Microorganisms, 2022 Antibiotic resistance is one of the major challenges that humankind shall face in the short term. (Bacterio)phage therapy is a valuable therapeutic alternative to antibiotics and, although the concept is almost as old as the discovery of phages, its wide
Roberto Vázquez +10 more
doaj +1 more source
Compassion on University Degree Programmes at a UK University: The Neuroscience of Effective Group work [PDF]
, 2018 This article is published under the Creative Commons Attribution (CC BY 4.0) licence. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution ...
Beka, Dr Sylvia +5 more
core +3 more sources
Frontiers in Medicine, 2023 When seriously ill patients have exhausted all treatment options available as part of usual care, the use of investigational agents may be warranted. Food and Drug Administration’s (FDA) Expanded Access (EA) pathway provides a mechanism for these patient’
Meghan Morrison Joly +5 more
doaj +1 more source